Galantamine: A Pharmacoeconomic Review of its Use in Alzheimer's Disease
Year of publication: |
2002
|
---|---|
Authors: | Lyseng-Williamson, Katherine A. ; Plosker, Greg L. |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 20.2002, 13, p. 919-942
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Acetylcholinesterase inhibitors | Adis Drug Evaluations | Alzheimer's disease | Cost analysis | Donepezil | Galantamine | Pharmacoeconomics | Rivastigmine |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Management of Alzheimer's Disease: Defining the Role of Donepezil
Ibbotson, Tim, (2002)
-
Lyseng-Williamson, Katherine A., (2003)
-
Caro, J. Jaime, (2003)
- More ...
-
Memantine: A Pharmacoeconomic Review of its Use in Moderate-to-Severe Alzheimer's Disease
Plosker, Greg L., (2005)
-
Etanercept: A Pharmacoeconomic Review of its Use in Rheumatoid Arthritis
Lyseng-Williamson, Katherine A., (2004)
-
Lyseng-Williamson, Katherine A., (2007)
- More ...